Table 1.
Demographic features.
| All patients (n=266) | |
|---|---|
| Age (yrs, mean ± SD) | 67.25 ± 16.32 |
| Sex, n(%) | |
| Male | 177 (66.5%) |
| Female | 89 (33.5%) |
| Immunol deficiency, n(%) | |
| Yes | 34 (12.8%) |
| No | 232 (87.2%) |
| Fever, n(%) | |
| Yes | 63 (23.7%) |
| no | 203 (76.3%) |
| Underlying diseases, n(%) | |
| Asthma | 7 (2.6%) |
| Bronchiectasis | 61 (22.9%) |
| Pulmonary fibrosis | 2 (0.0%) |
| Chronic obstructive pulmonary disease (COPD) | 53 (19.9%) |
| Cardio cerebrovascular disease | 6 (2.3%) |
| Chronic kidney diseases | 1 (0.0%) |
| Malignancies | 9 (3.4%) |
| Blood laboratory examination (range) | |
| White blood cell, 109/L | 9.89 (2.27-34.17) |
| Neutrophil, % | 73.32 (10.5-94.9) |
| Hemoglobin, g/L | 123.38 (67–182) |
| Platelet, 109/L | 262.53 (31–585) |
| C-reactive protein, mg/L | 52.35 (0.05-274.4) |
| Procalcitonin, ng/mL (n=41) | 3.23 (0.01->50) |
| Clinical outcomes | |
| In-hospital mortality, n(%) | 6 (2.2%) |
| Length of hospital stay (d, mean ± SD) | 8.48 ± 3.90 |